Appendix 1: Membership and Terms of Reference of the Working Committee

Members

Affiliation

Area of expertise

Dr Ann Koehler (Chair)

Director, Communicable Disease Control Branch, SA Health

Clinical microbiology, communicable disease control, epidemiology

Prof Chris Baggoley

Chief Executive Officer of the Australian Commission on Safety and Quality in Healthcare

Safety and quality in healthcare

Clinical Prof Keryn Christiansen

Clinical Microbiologist, PathWest Laboratory Medicine, Royal Perth Hospital WA

Microbiology, infectious diseases, antimicrobial resistance and surveillance

Dr Liz Coates

Senior Consultant, Adelaide Dental Hospital. ADA representative

Infection control in dental settings

Professor Peter Collignon

Infectious diseases physician and microbiologist

Director, Infectious Diseases Unit and Microbiology Department, The Canberra Hospital.

Professor, School of Clinical Medicine, Australian National University, ACT

Antibiotic resistance and infection control in hospitals

Dr Celia Cooper

Director, Microbiology and Infectious Diseases, Children’s, Youth and Women’s Health Service, Adelaide

Infectious diseases, public health, and medicine

Dr Nick Demediuk

General Practitioner, Royal Australian College of General Practitioners

General practice, infection control in office based practice

Dr Sylvia Gandossi

Vice President, Australian Infection Control Association. Infection Control Consultant

Infection control practice in both the public and private health sectors

A/Prof Tom Gottlieb

Senior specialist in microbiology and infectious diseases

Department of Microbiology and Infectious Diseases, Concord Hospital, NSW

Microbiology, infectious diseases

Mr Brett Mitchell

Director, Tasmanian Infection Prevention and Control Unit, Department of Health and Human Services

Infection prevention and control in Australia and internationally

Assoc Prof Peter Morris

Paediatrician, NT Clinical Studies School, Royal Darwin Hospital and Menzies School of Health Research, Darwin

Indigenous health, evidence-based medicine

Terms of Reference

The Infection Control Steering Committee (the Committee) will oversee and provide expertise in the revision of the Infection control guidelines for the prevention of transmission of infectious disease in the health care setting (2004) (the Guidelines).

  1. The revision will take into account but not be limited to:
    • The current Infection control guidelines for the prevention of transmission of infectious disease in the health care setting (2004) produced by the CDNA
    • The best available current scientific evidence
    • NHMRC recommended standards on guideline development
    • Comments provided by the broader community and health care sector through feedback from the project’s stakeholder group, targeted consultations and public consultation
  2. The Committee will provide advice on the following areas of the Guidelines revision:
    • The scope and requirements of the systematic review
    • The formulation of recommendations from the results of the systematic review
    • The content of the Guidelines
    • The development of educational materials and companion documents
    • Identification of indicators for the purpose of evaluation and monitoring the guidelines implementation
    • The development of an implementation strategy; and
    • Key stakeholders to undertake liaison/consultation
  3. The Committee will provide regular reports on the progress of guideline development to the CEO of the NHMRC
  4. The Committee will provide the NHMRC CEO with a draft report for the CEO to seek advice from Council.